Patents-Review.com
ClassID:

20472 ⎘

A61K31/5685 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone

Recent Application in this class:
#1
20260069608
2026-03-12

Methods of Delivering Alcohol-Soluble Species Including DHEA, Pregnenolone, and Chrysin for Reducing Menopausal Symptoms with Microemulsion Delivery Systems

 #2
20260007620
2026-01-08

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #3
20250319084
2025-10-16

ENDOCRINE THERAPY AND ABEMACICLIB COMBINATION FOR THE ADJUVANT TREATMENT OF NODE-POSITIVE, EARLY STAGE, HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER

 #4
20250281407
2025-09-11

LIPID DEPOT FORMULATIONS

 #5
20250205180
2025-06-26

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #6
20250195540
2025-06-19

Use of dehydroepiandrosterone (DHEA) in preparation of drug for preventing and treating ophthalmic myopia, dosage forms of DHEA, and preparation methods of dosage forms

 #7
20250186510
2025-06-12

BACTERIAL COMPOSITION FOR USE IN TREATMENT OF SUBSTANCE USE DISORDER

 #8
20250177402
2025-06-05

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

 #9
20250170134
2025-05-29

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

 #10
20250152562
2025-05-15

Compositions to Enhance and Extend Quality of Life

 #11
20250064846
2025-02-27

TREATMENT AND PREVENTION OF TRIGEMINAL NEURALGIA

 #12
20250032509
2025-01-30

Testosterone Ester Triglyceride Formulations

 #13
20250025467
2025-01-23

DEUTERATED DERIVATIVES OF RUXOLITINIB

 #14
20250000878
2025-01-02

COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING

 #15
20250000788
2025-01-02

BIOCOMPATIBLE DEVICES FOR CELL-BASED THERAPIES AND RELATED METHODS

 #16
20240424001
2024-12-26

LOCAL DELIVERY OF GROWTH AND REPAIR PROMOTING COMPOUNDS FOR TREATING, REDUCING AND/OR PREVENTING STRESS URINARY INCONTINENCE AND FECAL INCONTINENCE

 #17
20240374617
2024-11-14

METHODS OF ACTIVATING MICROGLIAL CELLS

 #18
20240299502
2024-09-12

PHARMACEUTICALS AND DOSING MEANS FOR HUMAN AGING REVERSAL

 #19
20240293426
2024-09-05

INTRAVENOUS ISTAROXIME FOR THE TREATMENT OF ACUTE HEART FAILURE

 #20
20240238310
2024-07-18

MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS

 #21
20240197654
2024-06-20

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #22
20240180987
2024-06-06

Cannabigerol (CBG) products and methods of use

 #23
20240115662
2024-04-11

METHODS OF TREATING HYPOGONADOTROPIC HYPOGONADISM AND COGNITION IMPAIRMENT FOLLOWING A TRAUMATIC BRAIN INJURY

 #24
20240108637
2024-04-04

EPITESTOSTERONE SULPHATE AND/OR A STEROID SULFATASE INHIBITOR FOR USE IN TREATING OR IMPROVING AGE RELATED COGNITIVE IMPAIRMENT

 #25
20240108595
2024-04-04

COMPOSITIONS AND METHODS FOR REVERSING AGE-ASSOCIATED DENDRITIC SPINE LOSS

 #26
20240082270
2024-03-14

CANNABIGEROL (CBG) PRODUCTS AND METHODS OF USE

 #27
20240082213
2024-03-14

Composition for Preventing or Treating Obesity or Lipid-Related Metabolic Disorders

 #28
20240066034
2024-02-29

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

 #29
20240016808
2024-01-18

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

 #30
20230405020
2023-12-21

SULFATED C19 STEROID HORMONES TO TREAT AND/OR PREVENT PROTEOTOXICITY IN PROTEIN-AGGREGATION DISEASES

 #31
20230405011
2023-12-21

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

 #32
20230398121
2023-12-14

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

 #33
20230398085
2023-12-14

Method of treating cancer using selective estrogen receptor modulators

 #34
20230355629
2023-11-09

DEUTERATED DERIVATIVES OF RUXOLITINIB

 #35
20230326575
2023-10-12

SYSTEM AND METHOD FOR PROVIDING FERTILITY ENHANCING DIETARY RECOMMENDATIONS IN INDIVIDUALS WITH LOW TESTOSTERONE

 #36
20230310354
2023-10-05

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER

 #37
20230293548
2023-09-21

ISTAROXIME-CONTAINING INTRAVENOUS FORMULATION FOR THE TREATMENT OF ACUTE HEART FAILURE (AHF)

 #38
20230285276
2023-09-14

Implantable Medical Device for the Delivery of Aromatase Inhibitor

 #39
20230241030
2023-08-03

MACROGOL 15 HYDROXYSTEARATE FORMULATIONS

 #40
20230144197
2023-05-11

4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMINO]METHYL]PIPERIDIN-3-OL COMPOUNDS AND THEIR THERAPEUTIC USE

 #41
20230131271
2023-04-27

Method of treating cancer using selective estrogen receptor modulators

 #42
20230127581
2023-04-27

Microemulsion Delivery Systems for Alcohol-Soluble Species Including DHEA, Pregnenolone, and Chrysin for Reducing Menopausal Symptoms

 #43
20230072025
2023-03-09

Stimulation of Human Meibomian Gland Function

 #44
20230061048
2023-03-02

SELECTION OF PATIENTS FOR COMBINATION THERAPY

 #45
20230027339
2023-01-26

LIPID DEPOT FORMULATIONS

 #46
20220339176
2022-10-27

Methods of Treatments to Prolong Gestation and Complications of Menstruation or Gestation

 #47
20220202829
2022-06-30

NON-IRRITATING TESTOSTERONE EMULSIONS

 #48
20220193079
2022-06-23

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

 #49
20220184013
2022-06-16

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER

 #50
20220110893
2022-04-14

Method of treating cancer using selective estrogen receptor modulators

 #51
20220089780
2022-03-24

KLOTHO BETA

 #52
20220079955
2022-03-17

Testosterone ester triglyceride formulations

 #53
20220054502
2022-02-24

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

 #54
20220040253
2022-02-10

Agonists of Human Kisspeptin Receptor for Modulating Sexual Desire

 #55
20220040202
2022-02-10

INHIBITORS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE FOR TREATING CARDIOVASCULAR AND PULMONARY CONDITIONS

 #56
20220023315
2022-01-27

METHODS OF ACTIVATING MICROGLIAL CELLS

 #57
20210393630
2021-12-23

ENDOCRINE THERAPY AND ABEMACICLIB COMBINATION FOR THE ADJUVANT TREATMENT OF NODE-POSITIVE, EARLY STAGE, HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER

 #58
20210393581
2021-12-23

Composition for preventing or treating obesity or lipid-related metabolic disorders

 #59
20210369734
2021-12-02

COMPOUNDS AND METHODS OF THEIR USE

 #60
20210346398
2021-11-11

COMBINATIONS WITH A C-19 STEROID FOR TREATING CANCERS

 #61
20210330674
2021-10-28

DEUTERATED DERIVATIVES OF RUXOLITINIB

 #62
20210308148
2021-10-07

PHARMACEUTICAL USE

 #63
20210290579
2021-09-23

Composition and uses for influencing hair growth

 #64
20210284753
2021-09-16

KLOTHO BETA

 #65
20210283144
2021-09-16

MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS

 #66
20210275497
2021-09-09

MACROGOL 15 HYDROXYSTEARATE FORMULATIONS

 #67
20210268002
2021-09-02

ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION

 #68
20210252017
2021-08-19

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

 #69
20210205256
2021-07-08

Compositions, Methods and/or Devices for Prevention and/or Treatment of Dry Eye Disorders

 #70
20210145945
2021-05-20

Radioprotection, Radiomitigation and Radiorecovery

 #71
20210137866
2021-05-13

Use of CYP26-resistant RAR alpha selective agonists in the treatment of cancer

 #72
20210137865
2021-05-13

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER

 #73
20210128672
2021-05-06

Gonadotropin-releasing hormones for use as adjuvant immunotherapeutics

 #74
20210128473
2021-05-06

LIPID DEPOT FORMULATIONS

 #75
20210113588
2021-04-22

NON-IRRITATING TESTOSTERONE EMULSIONS

 #76
20210069169
2021-03-11

PHARMACEUTICAL COMPOSITIONS

 #77
20210061847
2021-03-04

Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof

 #78
20210061846
2021-03-04

Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof

 #79
20210030767
2021-02-04

Formulations of testosterone and methods of treatment therewith

 #80
20210022992
2021-01-28

Sublingual therapeutic solutions and methods

 #81
20200390695
2020-12-17

TIME-RELEASE AND MICRO-DOSE FORMULATIONS FOR TOPICAL APPLICATION OF ESTROGEN AND ESTROGEN ANALOGS OR OTHER ESTROGEN RECEPTOR MODULATORS IN THE TREATMENT OF DRY EYE SYNDROME, AND METHODS OF PREPARATION AND APPLICATION

 #82
20200376005
2020-12-03

SHIP INHIBITION TO COMBAT OBESITY

 #83
20200376001
2020-12-03

USE OF ANDROGEN FOR TREATING GASTROINTESTINAL DISORDERS

 #84
20200368184
2020-11-26

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #85
20200352960
2020-11-12

Steroidal hormones for the treatment and prevention of wave burst arrhythmia

 #86
20200345736
2020-11-05

4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitors

 #87
20200306262
2020-10-01

COMPOUNDS AND METHODS OF THEIR USE

 #88
20200297820
2020-09-24

STIMULATION OF HUMAN MEIBOMIAN GLAND FUNCTION

 #89
20200297727
2020-09-24

Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas

 #90
20200289528
2020-09-17

Testosterone ester triglyceride formulations

 #91
20200282061
2020-09-10

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS

 #92
20200254066
2020-08-13

Pharmaceuticals and dosing means for human aging reversal

 #93
20200247838
2020-08-06

Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof

 #94
20200138832
2020-05-07

COMPOUNDS AND PRODRUGS THEREOF FOR THE TREATMENT OF OPHTHALMIC DISEASE

 #95
20200129586
2020-04-30

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ADRENOCORTICAL ACTIVITY AND/OR EXCESSIVE STEROID PRODUCTION

 #96
20200129525
2020-04-30

Method to improve quality of life in non-primate animals by administration of Dehydroepiandrosterone Sulfate (DHEAS) sufficient to achieve primate-specific levels of circulating DHEAS that are not natural to the target species

 #97
20200121621
2020-04-23

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #98
20200113905
2020-04-16

Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas

 #99
20200060963
2020-02-27

Sublingual therapeutic solutions and methods

 #100
20200054634
2020-02-20

ENDOCRINE THERAPY AND ABEMACICLIB COMBINATION FOR THE ADJUVANT TREATMENT OF NODE-POSITIVE, EARLY STAGE, HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER

 #101
20200046734
2020-02-13

Methods of Reducing Mammographic Breast Density and/or Breast Cancer Risk

 #102
20200016173
2020-01-16

Use of Exemestane for the Treatment of Gastric Cancer

 #103
20200009084
2020-01-09

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #104
20190350943
2019-11-21

(17-ß)-3-oxoandrost-4-en-17YL tridecanoate compositions and methods of their preparation and use

 #105
20190343844
2019-11-14

METHODS FOR THE TREATMENT OF BREAST CANCER

 #106
20190308976
2019-10-10

DEUTERATED DERIVATIVES OF RUXOLITINIB

 #107
20190307773
2019-10-10

Methods for treating testosterone deficiency in men and methods for precise dosing of UGT2B17 substrate drugs

 #108
20190298736
2019-10-03

Formulations of testosterone and methods of treatment therewith

 #109
20190290659
2019-09-26

Inhibitors of glucose-6-phosphate dehydrogenase for treating cardiovascular and pulmonary conditions

 #110
20190269697
2019-09-05

Method of treating and preventing loss of cognition

 #111
20190269696
2019-09-05

METHOD OF PREVENTING ALZHEIMIER'S DISEASE

 #112
20190240223
2019-08-08

Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas

 #113
20190240222
2019-08-08

Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas

 #114
20190216822
2019-07-18

TREATMENT OF SKIN ATROPHY WITH COMBINATION OF TRIIODOTHYROACETIC ACID (TRIAC) AND DEHYDROEPIANDROSTERONE (DHEA)

 #115
20190183905
2019-06-20

Pheromone compositions for stimulating early onset of estrus and reducing labor needs in breeding peri-pubertal suids and methods of use

 #116
20190099415
2019-04-04

COMBINATION THERAPY COMPOSITIONS AND METHODS FOR TREATING CANCERS

 #117
20190083421
2019-03-21

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #118
20190060326
2019-02-28

Testosterone ester triglyceride formulations

 #119
20190060289
2019-02-28

METHODS OF TREATING AUTOPHAGY-ASSOCIATED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS

 #120
20190046533
2019-02-14

Combination therapy for the treatment of cancer

 #121
20190022046
2019-01-24

Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders

 #122
20180369321
2018-12-27

Compositions and methods for treating conditions related to adrenocortical activity and/or excessive steroid production

 #123
20180353495
2018-12-13

PHARMACEUTICAL COMBINATIONS COMPRISING A PI3K INHIBITOR FOR THE TREATMENT OF CANCER

 #124
20180333380
2018-11-22

Use of CYP26-resistant RAR alpha selective agonists in the treatment of cancer

 #125
20180311163
2018-11-01

LIPID DEPOT FORMULATIONS

 #126
20180271880
2018-09-27

Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of sexual dysfunction in postmenopausal women

 #127
20180264117
2018-09-20

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS

 #128
20180263901
2018-09-20

Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application

 #129
20180255834
2018-09-13

A METHOD AND A DISPENSING ARRANGEMENT FOR TREATING A FLOW OF VAPORIZED LIQUID PROVIDED BY AN E-CIGARETTE AND AN E-CIGARETTE FOR THE ORAL INTAKE OF VAPORIZED LIQUID CONTAINING AN ADDITIONAL COMPOSITION

 #130
20180252721
2018-09-06

Selection of patients for combination therapy

 #131
20180235883
2018-08-23

Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

 #132
20180221388
2018-08-09

Non-irritating testosterone emulsions

 #133
20180193356
2018-07-12

Methods and compositions for treatment of non-alcoholic steatohepatitis

 #134
20180169112
2018-06-21

Pharmaceutical use

 #135
20180169004
2018-06-21

Sublingual therapeutic solutions and methods

 #136
20180153868
2018-06-07

TREATMENT OF BREAST CANCER BY CONCOMITANT ADMINISTRATION OF A BROMODOMAIN INHIBITOR AND A SECOND AGENT

 #137
20180125979
2018-05-10

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS

 #138
20180125844
2018-05-10

Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas

 #139
20180071314
2018-03-15

Dehydroandrosterol and methods of using the same

 #140
20180071313
2018-03-15

DRY EYE THERAPEUTIC AGENT COMPRISING NANDROLONE OR ESTER THEREOF OR METHENOLONE OR ESTER THEREOF AS AN ACTIVE INGREDIENT

 #141
20180044341
2018-02-15

4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatments

 #142
20180036395
2018-02-08

DOSAGE AND ADMINISTRATION OF MONOSPECIFIC AND BISPECIFIC ANTI-IGR-1R AND ANTI-ERBB3 ANTIBODIES

 #143
20170360804
2017-12-21

C-19 steroids for inhibiting neovascularization

 #144
20170360725
2017-12-21

FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer

 #145
20170354664
2017-12-14

Prodrugs of 17.BETA.-HSD1-inhibitors

 #146
20170340651
2017-11-30

COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING

 #147
20170319598
2017-11-09

Treatment of skin atrophy with a combination of triiodothyroacetic acid (TRIAC) and dehydroepiandrosterone (DHEA)

 #148
20170319597
2017-11-09

Methods of reducing mammographic breast density and/or breast cancer risk

 #149
20170304317
2017-10-26

DIETARY SUPPLEMENTS FOR MUSCLE GROWTH AND STRENGTH

 #150
20170290847
2017-10-12

Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM

 #151
20170281644
2017-10-05

Formulations of testosterone and methods of treatment therewith

 #152
20170246187
2017-08-31

(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE

 #153
20170242011
2017-08-24

Diagnosis and treatment of breast cancer

 #154
20170239270
2017-08-24

METHODS FOR TREATING CHRONIC OR UNRESOLVABLE PAIN AND/OR INCREASING THE PAIN THRESHOLD IN A SUBJECT AND PHARMACEUTICAL COMPOSITIONS FOR USE THEREIN

 #155
20170218456
2017-08-03

Systems, Devices and Methods for Constructing and Using a Biomarker

 #156
20170202823
2017-07-20

Method of treating cancer using selective estrogen receptor modulators

 #157
20170196887
2017-07-13

Method for the induction of phase 2 related genes in a mammal comprising administering exemestane

 #158
20170189412
2017-07-06

Androgen composition for treating an ophthalmic condition

 #159
20170176446
2017-06-22

Methods for Determining the Oncogenic Condition of Cell, Uses Thereof, and Methods for Treating Cancer

 #160
20170165246
2017-06-15

PHARMACEUTICAL COMBINATIONS COMPRISING A PI3K INHIBITOR FOR THE TREATMENT OF CANCER

 #161
20170042815
2017-02-16

Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

 #162
20160324808
2016-11-10

Method of treating cancer using selective estrogen receptor modulators

 #163
20160279144
2016-09-29

6-substituted estradiol derivatives for use in remyelination of nerve axons

 #164
20160184311
2016-06-30

Combination Therapy for the Treatment of Cancer

 #165
20160129017
2016-05-12

SHIP INHIBITION TO COMBAT OBESITY

 #166
20160058774
2016-03-03

Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of dyspareunia in postmenopausal women

 #167
20160022571
2016-01-28

IMPLANTABLE DRUG DELIVERY COMPOSITIONS COMPRISING NON-POLYMERIC SORPTION ENHANCERS AND METHODS OF TREATMENT THEREOF

 #168
20160015649
2016-01-21

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS

 #169
20160000852
2016-01-07

Nutrient combinations for affecting an aging process

 #170
20150374826
2015-12-31

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS

 #171
20150366800
2015-12-24

Androgen composition for treating an opthalmic condition

 #172
20150297510
2015-10-22

DHEA bioadhesive controlled release gel

 #173
20150274640
2015-10-01

Method of treating cancer using selective estrogen receptor modulators

 #174
20150250802
2015-09-10

Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM

 #175
20150246058
2015-09-03

COMPOSITION FOR PREVENTING HAIR LOSS AND ACCELERATING HAIR GROWTH

 #176
20150231219
2015-08-20

DOSAGE AND ADMINISTRATION OF MONOSPECIFIC AND BISPECIFIC ANTI-IGR-1R AND ANTI-ERBB3 ANTIBODIES

 #177
20150231124
2015-08-20

Pharmaceutical combination comprising a phosphatidylinositol 3-kinase inhibitor and/an aromatase inhibitor

 #178
20150157591
2015-06-11

Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders

 #179
20150148321
2015-05-28

SUBSTITUTED ANDROST-4-ENE DIONES

 #180
20150141328
2015-05-21

STIMULATION OF HUMAN MEIBOMIAN GLAND FUNCTION

 #181
20150104393
2015-04-16

Nutrient combinations for affecting an aging process

 #182
20150079189
2015-03-19

Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

 #183
20150064243
2015-03-05

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMININISTRATION OF HYDROPHOBIC DRUGS

 #184
20150025049
2015-01-22

Compositions comprising exemestane and novel methods of use

 #185
20150004214
2015-01-01

Vaginal ring comprising DHEA or DHEA sulfate and optionally a release-modulating agent of the active principle, useful to increase the ovarian reserve in women and to relieve symptoms associated with menopause

 #186
20140378529
2014-12-25

Collateral gene inactivation biomarkers and targets for cancer therapy

 #187
20140378420
2014-12-25

Methods for the treatment of breast cancer

 #188
20140343026
2014-11-20

Dosage form to increase prasterone bioavailability

 #189
20140315872
2014-10-23

Non-irritating testosterone emulsions

 #190
20140235598
2014-08-21

Tablet containing dehydroepiandrosterone (DHEA)

 #191
20140235540
2014-08-21

ANDROGEN AND GONADOTROPIN TREATMENT IN FEMALES

 #192
20140220152
2014-08-07

Compositions and Methods for Detecting, Treating, or Preventing Reductive Stress

 #193
20140193347
2014-07-10

LIPID DEPOT FORMULATIONS

 #194
20140135296
2014-05-15

Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits

 #195
20140134170
2014-05-15

USE OF INHIBITORS OF EGFR-FAMILY RECEPTORS IN THE TREATMENT OF HORMONE REFRACTORY BREAST CANCERS

 #196
20140106374
2014-04-17

Anti-FcRH5 antibodies and immunoconjugates and methods of use

 #197
20140088053
2014-03-27

Inhibitors of 17β-HSD1, 17β-HSD3 and 17β-HSD10

 #198
20140088050
2014-03-27

USE OF ANDROGEN FOR DISEASE TREATMENT

 #199
20140045806
2014-02-13

SEXUAL AROUSAL, SEXUAL DESIRE, ORGASM AND/OR PLEASURE FOLLOWING INTRAVAGINAL PRASTERONE (DHEA) ADMINISTRATION IN WOMEN NOT SUFFERING OR INDEPENDENTLY FROM DYSPAREUNIA OR OTHER SYMPTOMS OF VULVO-VAGINAL ATROPHY

 #200
20140038930
2014-02-06

Androgen treatment in females

 #201
20140031326
2014-01-30

Methods for the treatment of fibromyalgia and chronic fatigue syndrome

 #202
20140018339
2014-01-16

Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein

 #203
20140018338
2014-01-16

Methods and assays for treating filoviridae infections

 #204
20140011788
2014-01-09

Pharmaceutical composition and method for treating hypogonadism

 #205
20140011787
2014-01-09

Androgen treatment in females

 #206
20140011781
2014-01-09

METHOD FOR TREATING OR PREVENTING ANEMIA USING TESTIS EXTRACT AS ACTIVE INGREDIENT

 #207
20140005187
2014-01-02

Oxidosqualene cyclase as a protein target for anticancer therapeutics

 #208
20130337091
2013-12-19

PHARMACEUTICAL USE

 #209
20130303501
2013-11-14

Pharmaceutical composition and method for treating hypogonadism

 #210
20130244989
2013-09-19

Treatment of Alzheimer's disease, loss of cognition, memory loss and dementia with sex steroid precursors in combination with selective estrogen receptor modulators

 #211
20130210783
2013-08-15

NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR

 #212
20130196963
2013-08-01

Topical steroidal formulations

 #213
20130196959
2013-08-01

Topical steroidal formulations

 #214
20130157988
2013-06-20

Substituted androst-4-ene diones

 #215
20130142890
2013-06-06

Composition and uses for influencing hair growth

 #216
20130089555
2013-04-11

Anti-FcRH5 antibodies and immunoconjugates and methods of use

 #217
20130072466
2013-03-21

COMPOSITION CONTAINING PLACENTA EXTRACTS

 #218
20130065853
2013-03-14

Contraceptive methods and compositions

 #219
20130064815
2013-03-14

INDUCING APOPTOSIS IN QUIESCENT CELLS

 #220
20130059877
2013-03-07

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

 #221
20130023504
2013-01-24

Modulation of Prostaglandin/Cyclooxygenase Metabolic Pathways

 #222
20130018025
2013-01-17

Anticancer compound

 #223
20130018022
2013-01-17

PHARMACEUTICAL COMPOSITION INCLUDING A TESTIS EXTRACT AS AN ACTIVE INGREDIENT FOR TREATING AND PREVENTING ANEMIA

 #224
20130005700
2013-01-03

Pharmaceutical compositions

 #225
20130005665
2013-01-03

MACROGOL 15 HYDROXYSTEARATE FORMULATIONS

 #226
20120322778
2012-12-20

Pharmaceutical compositions

 #227
20120283285
2012-11-08

Treatment of solid tumors with rapamycin derivatives

 #228
20120283230
2012-11-08

Pharmaceutical compositions

 #229
20120276197
2012-11-01

Dosage form to increase prasterone bioavailability

 #230
20120269772
2012-10-25

Lipid depot formulations

 #231
20120245131
2012-09-27

6-substituted estradiol derivatives for use in remyelination of nerve axons

 #232
20120237502
2012-09-20

METHOD FOR TREATING BREAST CANCER AND OVARIAN CANCER

 #233
20120225064
2012-09-06

Sphingosine 1-Phosphate Antagonism

 #234
20120214778
2012-08-23

FULVESTRANT IN A DOSAGE OF 500mg FOR THE TREATMENT OF ADVANCED BREAST CANCER

 #235
20120214774
2012-08-23

Treatment of solid tumors with rapamycin derivatives

 #236
20120190661
2012-07-26

Androgen composition for treating an opthalmic condition

 #237
20120164213
2012-06-28

Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application

 #238
20120156202
2012-06-21

AGE RELATED MACULAR DEGENERATION TREATMENT

 #239
20120142645
2012-06-07

NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE FOR LOWERING CHOLESTEROL

 #240
20120130199
2012-05-24

Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein

 #241
20120121620
2012-05-17

ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER

 #242
20120100124
2012-04-26

METHODS FOR DETERMINING THE ONCOGENIC CONDITION OF CELL, USES THEREOF, AND METHODS FOR TREATING CANCER

 #243
20120071454
2012-03-22

Steroid compounds and treatment methods

 #244
20120039851
2012-02-16

Use of androgens for vascular regeneration and endothelial repair

 #245
20120030779
2012-02-02

COMPOSITIONS AND METHODS FOR DETECTING, TREATING, OR PREVENTING REDUCTIVE STRESS

 #246
20120029260
2012-02-02

Screening and Treatment Method

 #247
20120009582
2012-01-12

Diagnosis and treatment of breast cancer

 #248
20110262540
2011-10-27

Solid Pharmaceutical Composition Comprising Exemestane

 #249
20110209699
2011-09-01

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LIPOXYGENASE INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 #250
20110201586
2011-08-18

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM

 #251
20110201579
2011-08-18

Method of Improving the Overall Health of a Patient by Application of Pregnenolone

 #252
20110190244
2011-08-04

METHOD OF TREATMENT OF EGFR INHIBITOR TOXICITY

 #253
20110172196
2011-07-14

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM

 #254
20110166232
2011-07-07

Enhancement of urogenital function

 #255
20110124617
2011-05-26

Combination Therapy for BreastCancer Comprising an Antiestrogenic Agent

 #256
20110117218
2011-05-19

Composition and uses for influencing hair growth

 #257
20110098260
2011-04-28

Steroid compounds and formulations

 #258
20110086828
2011-04-14

TREATMENT OF ALCOHOL ABUSE AND ALCOHOLISM USING MODULATORS OF NEUROSTEROID BINDING SITES ON GABAA RECEPTORS

 #259
20110085984
2011-04-14

Drug Product and Process for Making

 #260
20110053900
2011-03-03

PROGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF BREAST CANCER

 #261
20110052678
2011-03-03

METHOD FOR TREATING AGE RELATED MACULAR DEGENERATION

 #262
20110034429
2011-02-10

5a-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR

 #263
20110009373
2011-01-13

COMPOSITION COMPRISING A COMBINATION OF AN AROMATASE INHIBITOR, A PROGESTIN AND AN OESTROGEN AND ITS USE FOR THE TREATMENT OF ENDOMETRIOSIS

 #264
20100324006
2010-12-23

Hormone delivery system and method

 #265
20100317639
2010-12-16

Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids

 #266
20100317635
2010-12-16

TREATMENT OF HOT FLUSHES, VASOMOTOR SYMPTOMS, AND NIGHT SWEATS WITH SEX STEROID PRECURSORS IN COMBINATION WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #267
20100303825
2010-12-02

Anti-estrogen and immune modulator combinations for treating breast cancer

 #268
20100292150
2010-11-18

Treatment of Menorrhagia with Aromatase Inhibitor

 #269
20100260748
2010-10-14

Anti-FcRH5 antibodies and immunoconjugates and methods of use

 #270
20100240633
2010-09-23

Cancer treatment methods

 #271
20100222313
2010-09-02

Pharmaceutical compositions-4

 #272
20100210613
2010-08-19

Transdermally absorbable preparation

 #273
20100173883
2010-07-08

7-HYDROXYEPIANDROSTERONE HAVING NEUROPROTECTIVE ACTIVITY

 #274
20100160274
2010-06-24

7-KETO DHEA for Psychiatric Use

 #275
20100158914
2010-06-24

KLOTHO BETA

 #276
20100137271
2010-06-03

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS

 #277
20100137270
2010-06-03

MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS

 #278
20100136105
2010-06-03

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS

 #279
20100113407
2010-05-06

Androgen treatment in females

 #280
20100105640
2010-04-29

Aromatase Inhibitors for Emergency Contraception

 #281
20100069340
2010-03-18

PHARMACEUTICAL COMPOSITIONS OF AN SRC KINASE INHIBITOR AND AN AROMATASE INHIBITOR

 #282
20100048525
2010-02-25

Androgen treatment in females

 #283
20100041631
2010-02-18

METHODS AND AGENTS FOR TREATING TUBERCULOSIS

 #284
20100004217
2010-01-07

Topical steroidal formulations

 #285
20090317476
2009-12-24

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LEUKOTRIENE RECEPTOR ANTAGONIST FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 #286
20090306031
2009-12-10

5alpha-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR

 #287
20090285900
2009-11-19

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A BETA-AGONIST BRONCHODILATOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 #288
20090274676
2009-11-05

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A PDE-4 INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 #289
20090263381
2009-10-22

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH AN ANTI-IGE ANTIBODY FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 #290
20090226453
2009-09-10

Sphingosine 1-phosphate antagonism

 #291
20090215737
2009-08-27

Pharmaceutical Compositions - 2

 #292
20090203658
2009-08-13

NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR

 #293
20090087389
2009-04-02

DEHYDROEPIANDROSTERONE SULFATE DIHYDRATE INHALATION COMPOSITIONS AND METHODS

 #294
20090054385
2009-02-26

SOLID INHALATION FORMULATIONS OF DEHYDROEPIANDROSTERONE DERIVATIVES

 #295
20090054383
2009-02-26

Pharmaceutical compositions

 #296
20090053143
2009-02-26

LIQUID INHALATION FORMULATIONS OF DEHYDROEPIANDROSTERONE DERIVATIVES

 #297
20090036435
2009-02-05

Pharmaceutical Compounds

 #298
20080292709
2008-11-27

KITS FOR DHEA AND DHEA-SULFATE FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 #299
20080279789
2008-11-13

Combination Of Dehydroepiandrosterone Or Dehydroepiandrosterone-Sulfate With An Anticholinergic Bronchodilator For Treatment Of Asthma Or Chronic Obstructive Pulmonary Disease

 #300
20080176824
2008-07-24

Pharmaceutical compositions 3